Please log in
to access more information

loading...

User name and Password not recognised

Home Page > News > Biom’up provides 2019 guidance for HEMOBLAST™ Bellows global sales

Biom’up provides 2019 guidance for HEMOBLAST™ Bellows global sales

Saint-Priest, France, May 20, 2019 - 8h00 (CET) - Biom’up (the « Company »), specializing in surgical hemostasis, is providing for the first time, full-year 2019 guidance for global sales of HEMOBLAST Bellows (including its laparoscopic applicator) in the range of €4.0-4.5 million.

 

  • Biom’up provides full-year 2019 guidance for global sales of HEMOBLAST Bellows in the range of €4.0-4.5 million
  • 2019 operational expenditures forecasted to decrease significantly versus 2018
  • Operational break-even on a quarterly basis expected during 2H 2021

 

» Read more